Literature DB >> 24674988

Measurement of concentrations of whole blood levels of choline, betaine, and dimethylglycine and their relations to plasma levels.

Hussain Mohamad Awwad1, Susanne H Kirsch2, Juergen Geisel2, Rima Obeid3.   

Abstract

We aimed at developing a method for the measurement of choline and its metabolites in whole blood (WB). After an extraction step, quantification of choline, betaine, and dimethylglycine (DMG) was performed using ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Plasma and WB metabolites were evaluated in a group of 61 elderly people. The calibration curves were linear (r(2)>0.997) for all compounds. The inter- and intra-assay coefficients of variation for all analytes were <10%. The recoveries were >90% and the relative matrix effect were ≤4.0%. The median concentrations of choline, betaine, and DMG were 11.3, 27.8, and 5.9μmol/L in plasma and 66.6, 165, and 13.7μmol/L in WB, respectively. There were positive correlations between WB and plasma markers; for choline (r=0.42), betaine (r=0.61), and DMG (r=0.56) (all p≤0.001). The concentrations of betaine in WB and plasma were significantly higher in men than in women. The concentrations of WB choline and DMG did not differ significantly according to sex. In conclusion, we have established a reliable method for measuring choline metabolites in WB. The concentrations of WB choline, betaine, and DMG seem to reflect intracellular concentrations of these metabolites.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Betaine; Choline; Dimethylglycine; Homocysteine; Whole blood

Mesh:

Substances:

Year:  2014        PMID: 24674988     DOI: 10.1016/j.jchromb.2014.02.030

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress.

Authors:  Leena S Knight; Quinn Piibe; Ian Lambie; Christopher Perkins; Paul H Yancey
Journal:  Neurochem Res       Date:  2017-09-16       Impact factor: 3.996

Review 2.  Defining nephrotic syndrome from an integrative genomics perspective.

Authors:  Matthew G Sampson; Jeffrey B Hodgin; Matthias Kretzler
Journal:  Pediatr Nephrol       Date:  2014-06-03       Impact factor: 3.714

3.  High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study.

Authors:  Erwin Garcia; Maryse C J Osté; Dennis W Bennett; Elias J Jeyarajah; Irina Shalaurova; Eke G Gruppen; Stanley L Hazen; James D Otvos; Stephan J L Bakker; Robin P F Dullaart; Margery A Connelly
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

4.  Systemic administration of choline acetyltransferase decreases blood pressure in murine hypertension.

Authors:  Andrew Stiegler; Jian-Hua Li; Vivek Shah; Tea Tsaava; Aisling Tynan; Huan Yang; Yehuda Tamari; Michael Brines; Kevin J Tracey; Sangeeta S Chavan
Journal:  Mol Med       Date:  2021-10-21       Impact factor: 6.354

5.  Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults.

Authors:  Hana Zahed; Mattias Johansson; Per M Ueland; Øivind Midttun; Roger L Milne; Graham G Giles; Jonas Manjer; Malte Sandsveden; Arnulf Langhammer; Elin Pettersen Sørgjerd; Kjell Grankvist; Mikael Johansson; Neal D Freedman; Wen-Yi Huang; Chu Chen; Ross Prentice; Victoria L Stevens; Ying Wang; Loic Le Marchand; Lynne R Wilkens; Stephanie J Weinstein; Demetrius Albanes; Qiuyin Cai; William J Blot; Alan A Arslan; Anne Zeleniuch-Jacquotte; Xiao-Ou Shu; Wei Zheng; Jian-Min Yuan; Woon-Puay Koh; Kala Visvanathan; Howard D Sesso; Xuehong Zhang; J Michael Gaziano; Anouar Fanidi; David Muller; Paul Brennan; Florence Guida; Hilary A Robbins
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.